Harry M Meade

This inventor holds 22 USPTO granted patents and 14 published patent applications, plus 1 CIPO patent and 4 EPO patents, primarily in Transgenic Protein Production. Top assignees: Gtc Biotherapeutics, Inc., Genzyme Transgenics Corporation, Biogen, Incorporated. Active years: 1989-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Harry M Meade. Retrieved from https://idiyas.com/inventor/harry-m-meade

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 22 (Patent Applications = 14)

% Patents Active = 59.1

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 4 (Patent Applications = 12)

Average Co-Inventor Count = 2.4

ph-index = 11

Forward Citations = 1,233(Granted Patents)

Location History:

Newtown, MA (US) (2006)
Newton, MA (US) (1989 - 2019)

Company Filing History:

8 out of 11

Gtc Biotherapeutics, Inc.

patents

5 out of 12

Genzyme Transgenics Corporation

Laboratoire Francais Du Fractionnement Et Des Biotechnologies

Genzyme Transgenic Corporation

patent

7. 1 out of 1

Genzyme Transgenics Corporatiion

Years Active: 1989-2019

Loading Chart...

Areas of Expertise:

Transgenic Antibodies

Glycosylation Modifications

Antithrombin III

Fusion Proteins

Erythropoietin Analog

Recombinant Proteins

Non-Human Mammals

Modified Nucleic Acids

Protein Expression

Mammary Gland Cells

Streptavidin-Like Polypeptides

mRNA Levels

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10174110 - Highly galactosylated anti-TNF-α antibodies and uses thereof (2019-01-08),

2. 10034921 - Proteins with modified glycosylation and methods of production thereof (2018-07-31),

3. 8173860 - Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion (2012-05-08),

4. 7928064 - Transgenically produced antithrombin III (2011-04-19),

5. 7632980 - Modified nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems (2009-12-15),

6. 7550263 - Method for the production of fusion proteins in transgenic mammal milk (2009-06-23),

7. 7501553 - Non-human transgenic mammal comprising a modified MSP-1 nucleic acid (2009-03-10),

8. 7354594 - Merozoite surface protein 1 lacking glycosylation sites (2008-04-08),

9. 7101971 - Erythropoietin analog-human serum albumin fusion (2006-09-05),

10. 7019193 - Treatments using transgenic goat produced antithrombin III (2006-03-28),

11. 6593463 - Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems (2003-07-15),

12. 6548653 - Erythropoietin analog-human serum albumin fusion (2003-04-15),

13. 6528699 - Transgenically produced non-secreted proteins (2003-03-04),

14. 6441145 - Transgenically produced Antithrombin III (2002-08-27),

15. 5849992 - Transgenic production of antibodies in milk (1998-12-15),

Title: The Innovative Journey of Harry M Meade

Introduction: Harry M Meade is a distinguished inventor based in Newton, MA (US) known for his groundbreaking contributions to various fields.

Latest Patents: Harry M Meade holds several patents in the areas of technology, healthcare, and consumer products, showcasing his diverse range of expertise.

Career Highlights: With a career spanning over two decades, Harry M Meade has consistently pushed the boundaries of innovation, leading to significant advancements in his respective industries.

Collaborations: Throughout his career, Harry M Meade has collaborated with leading research institutions, universities, and companies to bring his inventions to life, further solidifying his reputation as a visionary inventor.

Conclusion: Harry M Meade's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.